SFI
EGRX

Susquehanna Fundamental Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,749
Closed -$240K – 1808
2021
Q1 		$240K Sell
5,749
-7,753
-57% -$324K ﹤0.01% 1358
2020
Q4 		$629K Sell
13,502
-548
-4% -$25.5K 0.01% 1020
2020
Q3 		$597K Buy
14,050
+3,400
+32% +$144K 0.02% 822
2020
Q2 		$511K Buy
+10,650
New +$511K 0.02% 610